Science for patient advocates
A study week taking patient advocates from bedside to bench
We are pleased to announce that the VOICE course will once again be residential and held at Barts Cancer Centre from the 4th to 8th September 2022.
Members of ICPV are actively involved in many areas of research. To facilitate and enhance our role in these activities, members aim to understand the fundamentals of cancer, study design and current areas of controversy and research.
Much of this is gained through experience. However, working with the internationally renowned Barts Cancer Institute we have developed a tailor-made course which provides a week-long intensive training in basic cancer biology, introduction to research terminology and study design, and critical evaluation of research proposals and scientific papers. We have called this course VOICE (Vision On Information, Confidence and Engagement) Science for patient advocates. This course is unique, the only course of this type in the UK.
VOICE aims to give participants:
- An introduction to basic cancer biology
This will include sessions on what cancer is, how it is caused, how it develops and how it is detected and treated. Course participants will spend time in the research laboratories to help them to build their understanding.
- An introduction to epidemiology, statistics and reading scientific papers
This will include sessions on on understanding statistics, understanding risk, epidemiology and how to read and interpret scientific papers.
We hope that this course will give participants increased confidence to become more effectively involved in cancer research as patient advocates.
For full details please download the flyer below.
Poster presented at NCRI 2014
ICPV NCRI 2014.pdf
Adobe Acrobat document [363.5 KB]
For information on forthcoming courses please contact us.
We are pleased to announce that the VOICE course will be residential and held at Barts Cancer Centre from 4-8 Sept. Click here for further details.
OPTIMA is a patient driven clinical study for people with hormone sensitive early breast cancer.
On the 25th March we held an interactive talk and discussion on immunology.
The talk was given by Dr Edd James, Cancer Immunologist from the university of Southampton. The tallk is now available on YouTube - click here to listen.
Long Term Survivor Study
Continuum Life Sciences are looking for volunteers who have survived aggressive, difficult to treat cancer against all odds to take part in their Long-Term Survivor of Cancer Study. For more information and how you can join go to their website.
Save the planet and donate to ICPV - send ecards go tour Fundraising page for mor information.
FAST-Forward Trial Results
A one-week course of radiotherapy in fewer but larger daily doses was found to be as safe and effective as standard three-week therapy for women following surgery for early stage breast cancer. Trial results now published. Two ICPV members provided the PPI for this key trial. Full details can be found on the ICR Website.
ICPV Brighton Summer School Aug 2019
ICPV was once again hosted by SHORE-C at the University of Sussex. Click here for more info.
San Antonio Breast Cancer Symposium, 2018
ICPV member Pat Fairbrother attended this event on an Alamo Foundation Scholarship. Click here to read her review.
Gap Analysis in Breast Surgery Published
The 2013 Breast Cancer Campaign gap analysis established breast cancer research priorities without a specific focus on surgical research or the role of surgeons on breast cancer research. This Review aims to identify opportunities and priorities for research in breast surgery to complement the 2013 gap analysis. Click here for more information
ICPV Review 2018
We have at last published a new edition of our review. This was achieved by a grant from Novartis. Click here for more information.
Award for ICPV Member
Many congratulations to ICPV member Margaret Grayson. On 21 April 2018 she received the Iris Colvin Lifetime Achievement Award for Health, presented by the Women’s Forum of Northern Ireland. This is very well deserved for her tireless work in furthering cancer research especially in Northern Ireland.